Videos de Experimentos Relacionados

Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·2001

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

Same journal

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Lancet (London, England)·2026

Same journal

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Lancet (London, England)·2026

Ver todos los artículos relacionados

Videos de Experimentos Relacionados

Sistema de trasplante de EE.UU. Sistema de trasplante de EE.UU.

Videos de Conceptos Relacionados

Artículos Relacionados

Tacrolimus is associated with a lower incidence of cardiovascular complications in liver transplant recipients.

Late mortality after orthotopic liver transplantation.

Successful treatment of aggressive post transplant lymphoproliferative disorder using rituximab.

Pharmacoeconomic study of tacrolimus-based versus cyclosporine-based immunosuppressive therapy following liver transplantation.

Prophylactic antiviral therapy in CMV high-risk liver transplant recipients.

Treatment of progressive hepatitis C recurrence after liver transplantation with combination interferon plus ribavirin.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.

Videos de Experimentos Relacionados

Sistema de trasplante de EE.UU. Sistema de trasplante de EE.UU.

Videos de Conceptos Relacionados

Artículos Relacionados

Tacrolimus is associated with a lower incidence of cardiovascular complications in liver transplant recipients.

Late mortality after orthotopic liver transplantation.

Successful treatment of aggressive post transplant lymphoproliferative disorder using rituximab.

Pharmacoeconomic study of tacrolimus-based versus cyclosporine-based immunosuppressive therapy following liver transplantation.

Prophylactic antiviral therapy in CMV high-risk liver transplant recipients.

Treatment of progressive hepatitis C recurrence after liver transplantation with combination interferon plus ribavirin.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Dual mobility total hip replacement in fractures: stability promotes patient confidence.

Dual mobility versus standard cups in total hip replacement for displaced femoral neck fractures (Duality): an international, multicentre, randomised, controlled, superiority trial.